When is levosalbutamol (salbutamol) syrup indicated and what are the dosing recommendations for children (1‑5 years, >5 years) and adults?

When to Use Levosalbutamol (Salbutamol) Syrup

Levosalbutamol syrup should generally NOT be used, as inhaled formulations (nebulizer or MDI with spacer) are strongly preferred for acute bronchospasm because they provide superior bronchodilation with fewer systemic side effects. 1

Primary Indications for Short-Acting Beta-Agonists

Levosalbutamol (the R-enantiomer of racemic salbutamol) is indicated for:

• Acute relief of bronchospasm in asthma or reversible obstructive airway disease 2
• Prevention of exercise-induced bronchospasm when taken before activity 2
• Treatment of acute asthma exacerbations as first-line quick-relief medication 2, 1

Why Inhaled Routes Are Preferred Over Syrup

Nebulized or MDI delivery is the treatment of choice because:

• Inhaled beta-agonists deliver medication directly to the airways with markedly lower systemic drug concentrations 1
• Oral formulations (including syrups) have lower potency, slower onset of action, and greater systemic side effects compared to inhaled routes 1
• The 2007 NAEPP guidelines explicitly recommend short-acting beta-agonists via inhalation as the treatment of choice for acute symptom relief 2

Recommended Dosing When Inhaled Routes Are Used

For Acute Exacerbations (Nebulizer):

Children:

• Ages 1-5 years: 2.5 mg (0.15 mg/kg, minimum 2.5 mg) every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 3
• Ages >5 years: 2.5-5 mg every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 3
• Dilute in at least 3 mL normal saline and deliver at 6-8 L/min oxygen flow 1

Adults:

• 2.5-5 mg every 20 minutes for 3 doses during the first hour, then every 1-4 hours as needed 1
• For severe exacerbations, continuous nebulization at 10-15 mg/hour may be used 1

For Acute Exacerbations (MDI with Spacer):

Children and Adults:

• 4-8 puffs (90 mcg/puff = 360-720 mcg total) every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 3
• MDI with spacer is equally effective as nebulizer for mild-to-moderate exacerbations when proper technique is used 1

Levosalbutamol vs. Racemic Salbutamol Dosing:

• Levosalbutamol is administered at half the milligram dose of racemic salbutamol for comparable efficacy 1
• Levosalbutamol nebulizer: 1.25-2.5 mg (vs. 2.5-5 mg racemic) 1
• Levosalbutamol MDI: 45 mcg/puff (vs. 90 mcg/puff racemic) 1

Special Clinical Situations

Preoperative Use in Children with Upper Respiratory Infections:

• For children <6 years with URI undergoing general anesthesia, administer nebulized salbutamol 30 minutes before induction 2, 4
• Dose: 2.5 mg for children <20 kg; 5 mg for children >20 kg 2, 4
• This reduces perioperative cough and bronchospasm by approximately 50% 2, 4

Patients with Hypertension:

• Inhaled albuterol does not raise blood pressure in hypertensive patients 1
• Standard dosing is safe; do not withhold based on concerns about blood pressure 1

COPD Patients at Risk for CO₂ Retention:

• Use compressed air rather than oxygen as the driving gas for nebulization to avoid worsening hypercapnia 1

Monitoring and Safety

Watch for dose-dependent adverse effects:

• Tachycardia, tremor, hypokalemia, headache, and hyperglycemia 1
• These are generally mild and well-tolerated with inhaled administration 1

Signs requiring escalation of care:

• Inability to speak in complete sentences 1
• Altered mental status, intercostal retractions, worsening fatigue 1
• Oxygen saturation persistently <90% 1
• Silent chest on auscultation 1

Critical Pitfalls to Avoid

• Do not use oral syrup formulations when inhaled routes are available—they are inferior in efficacy and have more side effects 1
• Do not underdose in acute settings—the initial three-dose, 20-minute interval regimen is critical for adequate bronchodilation 1
• Do not use salbutamol >2 days per week for symptom relief (excluding pre-exercise use), as this indicates inadequate asthma control and need for controller therapy 2, 1
• Do not use regularly scheduled daily chronic dosing—salbutamol should be used only as-needed for symptom relief 2
• Do not substitute 2 puffs of MDI for a full nebulizer treatment in severe exacerbations—approximately 6-10 puffs with spacer approximate one nebulizer dose 1

Adjunctive Therapy for Moderate-to-Severe Exacerbations

• Add ipratropium bromide 0.5 mg to the first three salbutamol nebulizations for enhanced bronchodilation 1
• Initiate systemic corticosteroids early (prednisone 40-60 mg daily for adults; 1-2 mg/kg/day for children, max 60 mg/day) 1